发明名称 |
Anvendelse af sulfateret glycosaminoglycan til forbedring af biotilgængelighed af blodkoaguleringsfaktorer. |
摘要 |
The present invention relates to pharmaceutical preparations comprising one or more Factor VIII and a sulfated glycosaminoglycan for increasing the bioavailability of Factor VIII upon non-intravenous administration. The invention further relates to the combined use of Factor VIII and a sulfated glycosaminoglycan for the treatment and prevention of bleeding disorders, whereby the bioavailability of Factor VIII is increased, and to a method for increasing the bioavailability after non-intravenous administration of Factor VIII by coadminstration of a sulfated glycosaminoglycan. |
申请公布号 |
DK2768522(T3) |
申请公布日期 |
2016.11.14 |
申请号 |
DK20120777895T |
申请日期 |
2012.10.18 |
申请人 |
CSL Behring GmbH |
发明人 |
METZNER, Hubert.;ZOLLNER, Sabine. |
分类号 |
A61K38/36;A61K9/00;A61K38/37;A61K47/36;A61K47/42;A61P7/04 |
主分类号 |
A61K38/36 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|